MediGene chronicles

By BC Staff | Sep 11, 2006 | 7:00 AM GMT

MediGene chronicles

MediGene chroniclesSelected events tracked against MediGene’s weekly stock price (FSE:MDG). Y-axis = logarithmic scale A. 6/30/00 - Raises E125.4M ($117.4M) in an IPO. At that time, MDG was focused on developing therapeutics for cardiovascular and cancer indications. Lead programs included Etomoxir, about to start Phase II testing

Read the full 481 word article

How to gain access

Continue reading with a
two-week free trial.